By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
Currency | US Dollars |
Share Price | $ 116.64 |
Change Today | $ -1.22 |
% Change | -1.04 % |
52 Week High | $121.40 |
52 Week Low | $82.21 |
Volume | 2,252,419 |
Shares Issued | 1,246.00m |
Market Cap | $145,333m |
Beta | 0.00 |
RiskGrade | 120 |
Strong Buy | 9 |
Buy | 12 |
Neutral | 6 |
Sell | 1 |
Strong Sell | 0 |
Total | 28 |
Time | Volume / Share Price |
14:20 | 100 @ $116.64 |
14:20 | 100 @ $116.64 |
14:20 | 100 @ $116.64 |
14:20 | 100 @ $116.64 |
14:20 | 100 @ $116.62 |
You are here: research